Hypothalamic obesity is a form of severe, treatment-resistant weight gain caused by damage to the hypothalamus the brain region that regulates hunger and energy expenditure
doi: 10.1177/13872877251329439 [DOI] [PubMed] [Google Scholar] 125.Yang S, Zhao X, Zhang Y, et al
This trial also studied a cohort receiving either 2.4 mg of liraglutide or 3.0 mg of liraglutide, with reported weight reductions of 6.3 kg and 7.2 kg, respectively, when compared to baseline
2 Most people with MS are diagnosed between ages 20 and 50, and women are approximately 2.5 times more likely to develop the condition than men
Drugs that may increase the risk of hypoglycemia : antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors Drugs that may decrease the blood glucose lowering effect: atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones Drugs that may increase or decrease the blood glucose lowering effect : alcohol, beta-blockers, clonidine, lithium salts, and pentamidine Drugs that may blunt the signs and symptoms of hypoglycemia : beta-blockers, clonidine, guanethidine, and reserpine Please click here for Tresiba Prescribing Information
When a job candidate or employee is an approved medical marijuana user, they should inform the employer, Simo said
